Measuring the Impact of Integrating Maternal and Newborn HIV Testing With Childhood Immunization Services
A Cluster Randomised Trial on the Impact of Integrating Early Infant HIV Diagnosis With the Expanded Programme on Immunization on Immunization and HIV Testing Rates in Rural Zambian Health Facilities
1 other identifier
interventional
60
0 countries
N/A
Brief Summary
This randomized evaluation measured the impact of two levels of support for the integration of infant and postpartum maternal HIV testing with routine immunization services in Southern Zambia on the number of postpartum maternal HIV tests, infant HIV tests, and 1st dose diphtheria, pertussis, and tetanus (DPT1) vaccines.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable hiv
Started Oct 2013
Shorter than P25 for not_applicable hiv
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2014
CompletedFirst Submitted
Initial submission to the registry
June 14, 2015
CompletedFirst Posted
Study publicly available on registry
June 24, 2015
CompletedJuly 1, 2015
June 1, 2015
5 months
June 14, 2015
June 30, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Change in average monthly number of infant DBS HIV tests
Using a difference-in-differences analytic approach, the investigators analyzed counts of the number of infant dried blood spot (DBS) HIV tests administered per month at each of the 60 study facilities between Oct 2013 and Mar 2014 (intervention period), and compared it to retrospective baseline data from Jan 2012 - Sept 2013
Baseline and 6 mos (endline)
Change in average monthly number of maternal postpartum HIV tests
Using a difference-in-differences analytic approach, the investigators analyzed counts of the number of maternal postpartum HIV tests administered per month at each of the 60 study facilities between Oct 2013 and Mar 2014 (intervention period), and compared it to retrospective baseline data from Jan 2013 - Sept 2013
Baseline and 6 mos (endline)
Change in average monthly number of DPT1 doses administered
Using a difference-in-differences analytic approach, the investigators analyzed counts of the number of first dose diphtheria, pertussis, and tetanus vaccine (DPT1) administered per month at each of the 60 study facilities between Oct 2013 and Mar 2014 (intervention period), and compared it to retrospective baseline data from Jan 2012 - Sept 2013
Baseline and 6 mos (endline)
Study Arms (3)
Control
NO INTERVENTIONFacilities in this arm maintained status quo HIV testing and routine childhood immunization services
Simple Intervention
EXPERIMENTALThis included: 1) HIV testing commodity reinforcement and 2) a policy reinforcement meeting
Comprehensive Intervention
EXPERIMENTALThis arm included: 1) HIV testing commodity reinforcement, 2) a policy reinforcement meeting, 3) community sensitization, 4) Opt-out HIV testing for mothers and newborns, and 5) Operational support for service integration
Interventions
HIV testing commodities were replenished directly (outside of the government supply) in the event of a stock-out by study staff. Treatment facilities were visited monthly to assess stock levels, and facility staff could contact study staff when stock levels were low.
District health officials met with facility staff to remind them of the current HIV testing policies for mothers and newborns in Zambia. Current policy states mothers with unknown or previously negative status should be tested every 3 months until the infant is 18 months of age. HIV-exposed newborns should be tested at 6 weeks and 6 months.
Facility staff were instructed to examine the maternal HIV status on the under-five (U-5) or antenatal care (ANC) card for all infants attending their first U-5 visit and do the following: * If marked Confirmed Exposed (CE), the health care worker conducted the DBS test on the infant only. * If marked, Mother Status Unknown (MSU) or Confirmed Not Exposed (CNE) the mother or caregiver was asked if the mother had ever tested HIV-positive. If yes, a DBS was done on the infant only. If no, the mother was offered an HIV antibody test in an opt-out manner.
The evaluation team worked with facility staff to identify efficient allocations of staff and tailor the order of services. A key component of the operational optimization was a new patient triaging approach that sorted patient U-5 cards into bins and used separate queues for three types of patients: 1) first visit infants (six weeks), 2) second visit or later infants who required immunizations and 3) infants who were scheduled to only receive growth monitoring.
Health facility staff were instructed to communicate all aspects of the Comprehensive Intervention during ANC appointments, in-facility child birth deliveries, and postnatal care (PNC) visits. Additionally, at six week immunization visits, mothers and caregivers received group counseling on opt-out HIV screening service and the importance of regular HIV screening for mother and child health. Finally, the research team engaged Safe Motherhood Action Groups (SMAGs), community health workers (CHWs), and active neighborhood health committee members to further increase awareness in facility catchment areas. These community members completed low-touch community sensitization over changes that would be made to U-5 services.
Eligibility Criteria
You may qualify if:
- Mothers who had an infant within the past 18 months during the intervention period (Oct 2013 - Mar 2014)
- Infants who were at least six weeks of age and under six months of age during the intervention period (Oct 2013 - Mar 2014)
- Qualitative activities included facility staff and mothers and caregivers whose infants were due for their 6 week immunization during the intervention period.
You may not qualify if:
- Mothers who did not have an infant within the past 18 months during the intervention period
- Infants who were less than six weeks of age during the intervention period or greater than six months of age throughout out the intervention period.
- Adults who were not mothers or caregivers with an infant due for his/her 6 week immunization during the intervention period were excluded from the qualitative activities.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- IDinsightlead
- Zambia Center for Applied Health Research and Developmentcollaborator
- Ministry of Health, Zambiacollaborator
- Minister of Community Development, Mother and Child Health, Zambiacollaborator
- Clinton Health Access Initiative Inc.collaborator
Related Publications (1)
Wang PC, Mwango A, Moberley S, Brockman BJ, Connor AL, Kalesha-Masumbu P, Mutembo S, Bweupe M, Chanda-Kapata P, Biemba G, Hamer DH, Chibuye B, McCarthy E. A Cluster Randomised Trial on the Impact of Integrating Early Infant HIV Diagnosis with the Expanded Programme on Immunization on Immunization and HIV Testing Rates in Rural Health Facilities in Southern Zambia. PLoS One. 2015 Oct 29;10(10):e0141455. doi: 10.1371/journal.pone.0141455. eCollection 2015.
PMID: 26513240DERIVED
Study Officials
- PRINCIPAL INVESTIGATOR
Paul Wang, MPAID/MBA
IDinsight
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 14, 2015
First Posted
June 24, 2015
Study Start
October 1, 2013
Primary Completion
March 1, 2014
Study Completion
May 1, 2014
Last Updated
July 1, 2015
Record last verified: 2015-06